Company Can Fite Biopharma Ltd TEL AVIV STOCK EXCHANGE

IL0010944739

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Biopharmaceuticals

Inactive Instrument

Can Fite Biofarma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. It's technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.

ILS in Million	2022	Weight	2023	Weight	Delta
Biopharmaceuticals 100.0 %	3	100.0 %	3	100.0 %	+0.69%

ILS in Million	2022	Weight	2023	Weight	Delta
Israel 100.0 %	3	100.0 %	3	100.0 %	+0.69%

Managers	Title	Age	Since
Motti Farbstein CEO	Chief Executive Officer	59	03-07-31
Pnina Fishman FOU	Founder	74	94-09-10
Ilan Cohn FOU	Founder	67	94-09-10
Zivit Harpaz CTO	Chief Tech/Sci/R&D Officer	-	-
Michael Silverman CTO	Chief Tech/Sci/R&D Officer	-	-
Sari Fishman PRN	Corporate Officer/Principal	52	03-12-31
William D. Kerns PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Abraham Sartani BRD	Director/Board Member	76	00-12-31
Ilan Cohn FOU	Founder	67	94-09-10
Pnina Fishman FOU	Founder	74	94-09-10
Yaacov Goldman BRD	Director/Board Member	68	17-07-31
Guy Regev BRD	Director/Board Member	55	11-06-30
Yossi Bornstein BRD	Director/Board Member	66	21-08-04

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,497,128,493	1,496,706,120 ( 99.97 %)	0	99.97 %

Name	Equities	%	Valuation
IBI Mutual Funds Management (1978) Ltd. 0.1477 %	2,210,774	0.1477 %	16 890 ILa
Alumot Sprint Mutual Funds Management Ltd. 0.0730 %	1,092,174	0.0730 %	8 344 ILa
Pnina Fishman 0.0176 %	263,433	0.0176 %	2 013 ILa
Ilan Cohn 0.008922 %	133,567	0.008922 %	1 020 ILa
Guy Regev 0.001619 %	24,240	0.001619 %	185 ILa
Ramco Mutual Funds Management (1989) Ltd. 0.001469 %	22,000	0.001469 %	168 ILa
Millennium Mutual Funds Ltd. 0.000142 %	2,120	0.000142 %	16 ILa
Motti Farbstein 0.000076 %	1,133	0.000076 %	9 ILa
Sari Fishman 0.000000 %	0	0.000000 %	- ILa
Yossi Bornstein 0.000000 %	0	0.000000 %	- ILa

Name	Equities	%	Valuation
Armistice Capital LLC 3.093 %	154,363	3.093 %	342 686 ILa
Morgan Stanley Capital Services LLC 0.9271 %	46,265	0.9271 %	102 708 ILa
Schechter Investment Advisors LLC 0.4023 %	20,077	0.4023 %	44 571 ILa
RhumbLine Advisers LP 0.3703 %	18,482	0.3703 %	41 030 ILa
FIFTH THIRD BANCORP 0.0601 %	3,000	0.0601 %	6 660 ILa
National Bank Financial, Inc. 0.0120 %	600	0.0120 %	1 332 ILa
Citigroup Global Markets, Inc. (Investment Management) 0.0111 %	553	0.0111 %	1 228 ILa
Stone House Investment Management LLC 0.009418 %	470	0.009418 %	1 043 ILa
TD Waterhouse Canada, Inc. 0.000401 %	20	0.000401 %	44 ILa

Can-Fite BioPharma Ltd.

26 Ben Gurion Street

5257346, Ramat Gan

+972 3 924 1114

http://www.canfite.com

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Biopharmaceuticals

	1st Jan change	Capi.
CSL LIMITED	-3.95%	86.13B
SAMSUNG BIOLOGICS CO.,LTD.	+1.32%	39.82B
BIOGEN INC.	-19.27%	30.42B
UCB	+57.86%	25.23B
BIOMARIN PHARMACEUTICAL INC.	-16.09%	15.36B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.14%	11.95B
INCYTE CORPORATION	-17.69%	11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43.00%	11.51B
SWEDISH ORPHAN BIOVITRUM AB	+5.24%	8.71B

Biopharmaceuticals